Popular Peptides for Weight Loss
Not all peptides are created equal. Different compounds target different pathways, and the right choice depends on your goals, health history, and medical supervision. Here are the most well-researched options available today.
Semaglutide
Semaglutide is a GLP-1 receptor agonist that has dominated headlines for its impressive weight loss results. Originally developed for diabetes management, it received FDA approval for chronic weight management in 2021. Studies show participants using semaglutide lost an average of 15-20% of their body weight over 68 weeks when combined with diet and exercise support.
It works by slowing gastric emptying, reducing appetite, and increasing feelings of fullness after meals. The medication is typically administered via weekly subcutaneous injection, making it a convenient option for many patients.
Tirzepatide
Tirzepatide is a newer dual GIP/GLP-1 receptor agonist, meaning it targets two hormone pathways instead of one. This dual action appears to produce even more significant weight loss results in clinical trials. Some studies report average weight loss exceeding 20% of body weight.
Because it activates both pathways, tirzepatide may offer advantages for individuals who did not respond well to GLP-1 therapy alone. It is also administered weekly by injection and has shown strong safety profiles in trials.
AOD-9604
AOD-9604 is a fragment of human growth hormone specifically designed for fat loss without the other effects of full growth hormone. It is sometimes called a "lipolytic peptide" because its primary action is to stimulate fat breakdown.
Unlike peptides that suppress appetite, AOD-9604 works more directly on fat cells. It is often used by individuals who want the benefits of growth hormone for body composition without the hormone's broader systemic effects. Research suggests it may also help prevent fat re-accumulation after weight loss.